Atezolizumab,nivolumab,Pembrolizumab,Ipilimumab
merck,roche,bms
['nivo', 'clear,trial', 'atezo']
#immunotherapy for #kidneycancer great summary from as we learn on atezo and nivo trials that #adjuvant treatment has unclear role #esmo2022 
Grateful to work together to solve the challenge of cancer. Tweets my own opinion #FCOI https://t.co/2ohMdIEi0H